Effect of Butoconazole Nitrate 2% Vaginal Cream and Miconazole Nitrate 2% Vaginal Cream Treatments in Patients with Vulvovaginal Candidiasis
In a multicenter, randomized, invesgtigator-blind, parallel study, 398 patients were dispensed topical butoconazole nitrate 2% cream for 3 days (n = 199) or miconazole nitrate 2% cream for 7 days (n = 199) for vaginal use. Efficacy analyses included 254 patients with culture-confirmed Candida (119 b...
Saved in:
Main Authors: | Myra A. Lappin (Author), Doris C. Brooker (Author), Carol A. Francisco (Author), Joan Dorfman (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
1996-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Evaluation of Butoconazole Nitrate 2% Site Release® Vaginal Cream (Gynazole-1®) Compared to Fluconazole 150 mg Tablets (Diflucan®) in the Time to Relief of Symptoms in Patients With Vulvovaginal Candidiasis
by: Larry S. Seidman, et al.
Published: (2005) -
An Evaluation of Butoconazole Nitrate 2% Site ReleaseÃ,® Vaginal Cream (Gynazole-1Ã,®) Compared to Fluconazole 150 mg Tablets (DiflucanÃ,®) in the Time to Relief of Symptoms in Patients With Vulvovaginal Candidiasis
by: Campbell K. Skokos, et al.
Published: (2005) -
The effect of vaginal cream containing ginger in users of clotrimazole vaginal cream on vaginal candidiasis
by: Sheida Shabanian, et al.
Published: (2017) -
The possibilities of clindamycin and butoconazole containing vaginal cream in reducing the risk of recurrence of urogenital candidiasis in comorbid patients with bacterial vaginosis
by: G.S.Sergiyenko, et al.
Published: (2018) -
The possibilities of clindamycin and butoconazole containing vaginal cream in reducing the risk of recurrence of urogenital candidiasis in comorbid patients with bacterial vaginosis
by: G S Sergiyenko, et al.
Published: (2018)